Melvin E. Andersen

The Hamner Institutes for Health Sciences

Papers

2

Total Citations

2,001

H-Index

2

About

Melvin E. Andersen is a pioneering figure in computational toxicology and systems biology, whose work has fundamentally reshaped how chemical safety is assessed. His research integrates dosimetry, pharmacokinetics, and in vitro models to predict human health risks with greater accuracy and reduced reliance on animal testing. Andersen is best known for his central role in advancing the vision of *Toxicity Testing in the 21st Century*, a landmark National Academy of Sciences report (2010, 1,675 citations) that called for a paradigm shift toward mechanism-based, human-cell-derived testing. He further elaborated this transformative approach in a highly influential follow-up paper (2008, 326 citations), outlining how in vitro assays and computational models could replace traditional animal studies. Through his leadership at the Hamner Institutes for Health Sciences, Andersen has championed the development of physiologically based pharmacokinetic (PBPK) models and dose-response frameworks that now underpin regulatory decision-making worldwide. His work has earned him numerous accolades, including the Society of Toxicology’s Founders Award, and his contributions continue to guide a generation of researchers toward safer, more efficient, and ethically sound toxicity testing strategies.

Research Focus

Key Achievements

2
H-Index
2
Papers
2,001
Total Citations
1,001
Avg Citations/Paper
🏆 Most Cited Paper
Toxicity Testing in the 21st Century: A Vision and a Strategy
1,675 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: The Hamner Institutes for Health Sciences

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago